COL3A1 mutations cause variable clinical phenotypes including acrogeria and vascular rupture

British Journal of Dermatology

Volumn 135, Issue 2, 1996, Pages 163-181

  Pope, F M ^a,b,c   Narcisi, P ^b,c   Nicholls, A C ^b,c   Germaine, D ^d   Pals, G ^e   Richards, A J ^b,c  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d INSERM   (France)

^e VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 3;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CHILD; CLINICAL ARTICLE; EHLERS DANLOS SYNDROME; EXON; FEMALE; GENE AMPLIFICATION; GENE DELETION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; MALE; PRIORITY JOURNAL; SKIN DEFECT;

EID: 0029902127     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1996.tb01143.x     Document Type: Article

References (37)

1. Brighton P, de Paepe A, Danks D et al. International nosology of heritable disorders of connective tissue. Berlin, 1986. Am J Med Genet 1988; 29: 581-94.
2. Pope FM. Molecular abnormalities of collagen. In: Oxford Textbook of Rheumatology (PJ Maddison, DA Isenberg, P Woo, DN Glass, eds) Vol. 1. Oxford: Oxford University Press. 1993: 204-32.
3. Pousi B, Hautala T, Heikkinen J et al. Alu-Alu recombination results in a duplication of seven exons in the lysyl hydroxylase gene in a patient with the Type VI variant of Ehlers-Danlos syndrome. Am J Hum Genet 1994, 55: 899-906.
4. Nicholls AC, Oliver J. Renouf DV et al. Ehlers-Danlos syndrome type VII: a single base change that causes exon skipping in the type I collagen alpha 2(I) chain. Hum Genet 1991; 87: 193-8.
5. Nusgens BV, Verellen-Dumonlin CN, Hermanns-Le T et al. Evidence for a relationship between Ehlers-Danlos type VIIC in human and bovine dermatosporaxis. Nat Genet 1992; 1: 214-17.
6. Nicholls AC, McCann S, Narcisi P, Pope FM. Molecular abnormalities of type V collagen in Ehlers-Danlos syndrome. Abstract 1358. Am J Hum Genet 1994; 55: A233.
7. Ramirez F, Bernard M, Chu M-L et al. Isolation and characterization of the human fibrillar collagen genes. Ann NY Acad Sci 1985; 460: 117-29.
8. Ala-Kokko L, Kontusaari S, Baldwin C et al. Structure of cDNA clones coding for the entire pre-pro alpha (III) chain to type III procollagen. Differences in protein structure from type 1 procollagen and conservation of codon preferences. Biochem J 1989; 260: 509-16.
9. Janeczko RA, Ramirez F. Nucleotide and amino acid sequences of the entire human alpha 1 (III) collagen. Nucleic Acids Res 1989; 17: 6742.
10. Chu M-L, Prockop DJ. Collagen gene structure. In: Connective Tissue and its Heritable Disorders (PM Royce, B Steinman, eds) New York: Wiley Liss. 1993: 149-65.
11. Bazex A, Dupré A. Pace de l'acrogerie (acrogeria type Cottron) apropos d'une observation dans le cadre des atrophies cutanées congentiales. Ann Dermatol 1955; 82: 604-21.
12. McKusick VA. Heritable Disorders of Connective Tissue, 4th edn. St Louis: Mosby, 1972; 339-41.
13. Nicholls AC, De Paepe A. Narcisi P et al. Linkage of a polymorphic marker for the type III collagen gene (COL3A1) to atypical autosomal dominant Ehlers-Danlos syndrome type IV in a large Belgian Pedigree. Hum Genet 1988; 78: 276-81.
14. Myers RM, Maniatis T, Leman LS. Detection and localization of single base changes by denaturing gradient gel electrophoresis. Methods Enzymol 1987; 155: 501-27.
15. Pope FM, Nicholls AC. Narcisi P et al. Type III collagen mutations in Ehlers-Danlos syndrome type IV and other related disorders. Clin Exp Dermatol 1988; 13: 285-302.
16. Pope FM, Nicholls AC. Collagen genes and proteins in human diseases. In: Recent Advances in Dermatology. No. 7 (RH Champion, ed.). Edinburgh: Churchill Livingstone. 1989; 23-50.
17. Pope FM, Daw SEM, Narcisi P et al. Prenatal diagnosis and prevention of inherited abnormalities of collagen. J Inher Metab Dis 1989; 12(Suppl. 1): 135-173.
18. +6 mutation in the donor splice site of COL3A1 causes exon skipping and results in Ehlers-Danlos syndrome type IV. J Med Genet 1993; 30: 376-80.
19. Richards AJ, Lloyd JC, Ward PN et al. Characterisation of a glycine to valine substitution at amino acid 910 in the triple helical region of type III collagen in a patient with Ehlers-Danlos syndrome type IV. J Med Genet 1991; 28: 458-63.
20. Richards AJ, Ward PN, Narcisi P et al. A single base mutation in the gene for type III collagen (COL3A1) converts glycine 847 to glutamic acid in a family with Ehlers-Danlos syndrome type IV. An unaffected family member is mosaic for the mutation. Hum Genet 1992; 89: 414-18.
21. Richards AJ, Narcisi P, Lloyd J et al. The substitution of glycine 661 by arginine in type III collagen produces mutant molecules with different thermal stabilities and causes Ehlers-Danlos syndrome type IV. Med Genet 1993; 30: 690-3.
22. Johnson PH, Richards AJ, Pope FM. Hopkinson DA. A COL3A1 glycine 1006 to glutamic acid substitution in a patient with Ehlers-Danlos syndrome type IV detected by denaturing gradient gel electrophoresis. J Inher Metab Dis 1992; 15: 426-30.
23. Narcisi P, Wu Y, Tromp G et al. Single base mutation that substitutes glutamic acid for glycine 1021 in the COL3A1 gene causes Ehlers-Danlos syndrome IV. Am J Med Genet 1993; 46: 278-83.
24. Tromp G, Kuivaniemi H, Stolle C et al. Single base mutation in the type III procollagen gene that converts the codon for glycine 883 to aspartate in a mild variety of Ehlers-Danlos syndrome IV. J Biol Chem 1989; 264: 19313-17.
25. Johnson PH, Richards AJ, Lloyd JC et al. Efficient strategy for the detection of mutations in acrogeric Ehlers-Danlos syndrome type IV. Human Mutat 1995; 6: 336-42.
26. Milewicz DM, Witz AM, Smith AC et al. Parental, somatic and germline mosaicism for a multiexon deletion with unusual endpoints in a type III collagen (COL3A1) allele produces Ehlers-Danlos syndrome type IV in the heterozygous offspring. Am J Hum Genet 1993; 53: 62-70.
27. Richards AJ, Lloyd JC, Narcisi P et al. A 27bp depletion from one allele of the type III collagen gene (COL3A1) in a large family with Ehlers-Danlos syndrome type IV. Hum Genet 1992; 88: 325-30.
28. Richards AJ, Narcisi P, Ferguson C et al. Two new mutations affecting the donor splice site of COL3A1 IVS37 and causing skipping of exon 37 in patients with Ehlers-Danlos syndrome type IV. Hum Mol Genet 1994; 3: 1901-2.
29. Goldstein JA, Schwarze V, Witz A et al. Marked heterogeneity in COL3A1 mutations that produce the EDS type IV phenotype (abstract). Matrix Biol 1994; 14: 392-3.
30. Kuivaniemi H, Tromp G, Bergfeld WF et al. Ehlers-Danlos syndrome type IV: a single base substitution of the last nucleotide of exon 34 in COL3A1 leads to exon skipping. J Invest Dermatol 1995; 105: 352-6.
31. Morris D. Case report. Section of Paediatrics. Proc R Soc Med 1957; 50: 330-1.
32. Roberts DLL, Pope FM, Nicholls AC, Narcisi P. Ehlers-Danlos syndrome type IV mimicking non-accidental injury in a child. Br J Dermatol 1984; 111: 341-5.
33. Fox R, Pope FM, Narcisi P et al. Spontaneous carotid cavernous fistula in Ehlers-Danlos syndrome. J Neurol Neurosurg Psychiatry 1988; 51: 984-6.
34. Pope FM, Kendall BE, Slapak GI et al. Type III collagen mutations cause fragile cerebral arteries. Br J Neurosurg 1991; 5: 551-74.
35. Beighton P. The Ehlers-Danlos Syndrome. London: Heinemann. 1970.
36. Rudd NL, Nimrod C, Holbrook KA, Byers PH. Pregnancy complications in type IV Ehlers-Danlos syndrome. Lancet 1985; i: 50-3.
37. Pope FM, Nicholls AC. Pregnancy in Ehlers-Danlos syndrome type VI. Lancet 1983; i: 249-50.